CareDx Completes Sale Of Its Lab Products Operations To Eurobio Scientific For $171.2M

CareDx, Inc. (Nasdaq: CDNA ) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced the closing of the previously announced sale of its Lab Products business to Eurobio Scientific. The transaction closed on June 30, 2026 following receipt of required Swedish regulatory clearance.